|
Home | Medical-Newswire.Com:
|
(EMAILWIRE.COM, December 10, 2007 ) Bountiful, UT – WikiPatents.com, the online patent review community and marketplace, announces that Dr. Jaime Castano's optical method and device for determining blood glucose levels, US Patent 6,113,537, is available for sale or licensing. The patent buyer or licensee would be granted the right to develop and commercialize non-invasive blood glucose monitors for use by diabetics.
Dr. Castano’s Handheld Device Provides a Non-Invasive Way for Diabetics to Test Blood Glucose Levels
Two hundred million diabetics worldwide are expected to monitor their blood glucose level several times a day. Due to the pain, inconvenience, and cost of the traditional finger-pricking method, many diabetics do not test as often as they should. Dr. Castano's patented technology offers an appealing alternative: a completely non-invasive testing approach. The handheld device displays several sequences of moving lights on its screen. The user merely has to indicate via button-presses what he sees on the screen, and the microprocessor in the device calculates the user's current blood glucose level.
Dr. Castano's testing method works because a person's blood glucose level directly affects the sensitivity of two groups of cells in the visual system. The moving light patterns displayed on the device's screen are designed to measure the sensitivity of the target cells. Since the relative sensitivity of the target cells in the user's visual system correlates directly to blood glucose concentration (and not to other potentially interfering factors), the device can very accurately measure blood glucose levels without requiring a blood sample.
Non-Invasive Testing Device is Painless, Inconspicuous, and Requires No Disposable Supplies
The portable, light-weight, handheld device offers a better alternative to painful finger-prick testing because it requires no blood sample and no disposable supplies (such as the strips used in the finger-prick tests to collect the drawn blood). Young diabetics are the most difficult group to get to comply with invasive methods of blood glucose testing. Dr. Castano’s handheld device is no more conspicuous than a pocket calculator or portable video game, so young diabetics will be much more likely to test often.
Large, Rapidly Expanding Market Eager for a Non-Invasive Testing Method
Dr. Castano’s handheld, non-invasive technology provides an exciting opportunity for investors looking to make a healthy profit by developing a medical technology to enable diabetics to test their blood glucose levels in a low-cost, non-invasive manner. The current market size for blood glucose testing worldwide is $8 billion and is estimated at $2 billion in the USA alone. The market is projected to increase by 6% per year. Conservative estimates place annual sales in the U.S. for a non-invasive device at $43 million in 2009. Ten years later sales projections are estimated to be $211 million per year. Current estimates of U.S. and worldwide diabetics who regularly test (16% and 5%, respectively) are expected to increase after the non-invasive testing device becomes available, which will boost the above market projections.
Interested parties can learn more about the technology, see more details about the market size and projected sales, get in contact with the inventor, review and comment on the patent claims, discuss the value of the patent, and discuss the severity of the problem and the adequacy of Dr. Castano's solution at WikiPatents.com.
For more information on sale or license options for Dr. Castano’s patent and for information about the WikiPatents Marketplace, please visit:
http://www.wikipatents.com
WikiPatents.com
Kevin Hermansen
208-360-4043
kevin@wikipatents.com 
Source: EmailWire.com
|
|
|
|
